Society of Gynecologic Oncology Journal Club: Controversial conversations in Gynecologic cancer – The ABCs of ADCs (Antibody drug Conjugates)()

The Society of Gynecologic Oncology (SGO) Journal Club is held quarterly to discuss topics related to gynecological malignancies. On November 8, 2022, the SGO Journal Club focused on antibody-drug conjugates (ADCs) in gynecologic malignancies, including the pharmacology, toxicities, and results of r...

Descripción completa

Detalles Bibliográficos
Autores principales: Martin, J., Zacholski, E., O'Cearbhaill, R., Matulonis, U., Chen, L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
SGO Journal Club Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9931885/
https://www.ncbi.nlm.nih.gov/pubmed/36818197
http://dx.doi.org/10.1016/j.gore.2023.101141
_version_ 1784889329565302784
author Martin, J.
Zacholski, E.
O'Cearbhaill, R.
Matulonis, U.
Chen, L.
author_facet Martin, J.
Zacholski, E.
O'Cearbhaill, R.
Matulonis, U.
Chen, L.
author_sort Martin, J.
collection PubMed
description The Society of Gynecologic Oncology (SGO) Journal Club is held quarterly to discuss topics related to gynecological malignancies. On November 8, 2022, the SGO Journal Club focused on antibody-drug conjugates (ADCs) in gynecologic malignancies, including the pharmacology, toxicities, and results of recent clinical trials leading to FDA approval of two new therapies for cervical and ovarian cancer. The invited discussants included Drs. Erin Hickey Zacholski, Roisin O’Cearbhaill, and Ursula Matulonis who discussed the pharmacology of ADCs, GOG-3023/ENGOT-cx6 (Coleman et al., 2021 May) and the SORAYA study (Ursula Matulonis, Domenica Lorusso, Ana Oaknin, Sandro Pignata, Hannelore Denys, Nicoletta Colombo, Toon Van Gorp, Jason Konner, Margarita Romeo Marin, Philipp Harter, Conleth Murphy, Jiuzhou Wang, Elizabeth Noble, Brooke Esteves, Michael Method, Robert Coleman, Efficacy and Safety of Mirvetuximab Soravtansine in Patients with Platinum-Resistant Ovarian Cancer with High Folate Receptor Alpha Expression: Results from the SORAYA Study (LBA 4), Gynecologic Oncology, Volume 166, Supplement 1, ,2022).
format Online
Article
Text
id pubmed-9931885
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-99318852023-02-17 Society of Gynecologic Oncology Journal Club: Controversial conversations in Gynecologic cancer – The ABCs of ADCs (Antibody drug Conjugates)() Martin, J. Zacholski, E. O'Cearbhaill, R. Matulonis, U. Chen, L. Gynecol Oncol Rep SGO Journal Club Commentary The Society of Gynecologic Oncology (SGO) Journal Club is held quarterly to discuss topics related to gynecological malignancies. On November 8, 2022, the SGO Journal Club focused on antibody-drug conjugates (ADCs) in gynecologic malignancies, including the pharmacology, toxicities, and results of recent clinical trials leading to FDA approval of two new therapies for cervical and ovarian cancer. The invited discussants included Drs. Erin Hickey Zacholski, Roisin O’Cearbhaill, and Ursula Matulonis who discussed the pharmacology of ADCs, GOG-3023/ENGOT-cx6 (Coleman et al., 2021 May) and the SORAYA study (Ursula Matulonis, Domenica Lorusso, Ana Oaknin, Sandro Pignata, Hannelore Denys, Nicoletta Colombo, Toon Van Gorp, Jason Konner, Margarita Romeo Marin, Philipp Harter, Conleth Murphy, Jiuzhou Wang, Elizabeth Noble, Brooke Esteves, Michael Method, Robert Coleman, Efficacy and Safety of Mirvetuximab Soravtansine in Patients with Platinum-Resistant Ovarian Cancer with High Folate Receptor Alpha Expression: Results from the SORAYA Study (LBA 4), Gynecologic Oncology, Volume 166, Supplement 1, ,2022). Elsevier 2023-02-02 /pmc/articles/PMC9931885/ /pubmed/36818197 http://dx.doi.org/10.1016/j.gore.2023.101141 Text en © 2023 The Author(s) https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle SGO Journal Club Commentary
Martin, J.
Zacholski, E.
O'Cearbhaill, R.
Matulonis, U.
Chen, L.
Society of Gynecologic Oncology Journal Club: Controversial conversations in Gynecologic cancer – The ABCs of ADCs (Antibody drug Conjugates)()
title Society of Gynecologic Oncology Journal Club: Controversial conversations in Gynecologic cancer – The ABCs of ADCs (Antibody drug Conjugates)()
title_full Society of Gynecologic Oncology Journal Club: Controversial conversations in Gynecologic cancer – The ABCs of ADCs (Antibody drug Conjugates)()
title_fullStr Society of Gynecologic Oncology Journal Club: Controversial conversations in Gynecologic cancer – The ABCs of ADCs (Antibody drug Conjugates)()
title_full_unstemmed Society of Gynecologic Oncology Journal Club: Controversial conversations in Gynecologic cancer – The ABCs of ADCs (Antibody drug Conjugates)()
title_short Society of Gynecologic Oncology Journal Club: Controversial conversations in Gynecologic cancer – The ABCs of ADCs (Antibody drug Conjugates)()
title_sort society of gynecologic oncology journal club: controversial conversations in gynecologic cancer – the abcs of adcs (antibody drug conjugates)()
topic SGO Journal Club Commentary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9931885/
https://www.ncbi.nlm.nih.gov/pubmed/36818197
http://dx.doi.org/10.1016/j.gore.2023.101141
work_keys_str_mv AT martinj societyofgynecologiconcologyjournalclubcontroversialconversationsingynecologiccancertheabcsofadcsantibodydrugconjugates
AT zacholskie societyofgynecologiconcologyjournalclubcontroversialconversationsingynecologiccancertheabcsofadcsantibodydrugconjugates
AT ocearbhaillr societyofgynecologiconcologyjournalclubcontroversialconversationsingynecologiccancertheabcsofadcsantibodydrugconjugates
AT matulonisu societyofgynecologiconcologyjournalclubcontroversialconversationsingynecologiccancertheabcsofadcsantibodydrugconjugates
AT chenl societyofgynecologiconcologyjournalclubcontroversialconversationsingynecologiccancertheabcsofadcsantibodydrugconjugates

Ejemplares similares